Mr Mrs Miss Ms Dr Other

Ms
Roxna
Kapadia

Patent Director

London Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 735 042 6573
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

Roxna is a UK and European qualified Patent Attorney with a technical background in microbiology and immunology. She has in-depth knowledge and experience with viral cancer therapeutics, antibodies, microbiome, stem cells, immunotherapy, genetics and food science. Roxna has in-house patent experience working at the small biotechnology company Oncolytics Biotech Inc. and at the multinational company General Electric Healthcare and Merck Sharp & Dohme.

Roxna has experience working before the EPO, UKIPO and WIPO, including drafting and filing applications, prosecution and EPO oppositions and appeals. Roxna also has extensive experience with IP due diligence, validity opinions and FTO analysis. Having worked both in house and in private practice, Roxna is well placed to provide business focused strategic intellectual property advice to her clients.

Roxna is a named inventor on a patent for a method of purifying viruses using gel permeation chromatography. Roxna developed and ran industry-focused intellectual property courses in London UK, in particular Roxna has taught freedom to operate courses for the Life Sciences and Pharmaceutical Industry.

Having grown up in Canada and worked in Switzerland, Roxna is fluent in English and French.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Microbiology and Immunology

MSC

Immunology

MSC

Management of Intellectual Property

Publications

Bite-sized MBA Course

View publication online

Divergent Roles of Toll-like Receptor 2 in Response to Lipoteichoic acid and Staphylococcus aureus In Vivo.

View publication online

The Use of Immunohistochemistry to Determine Oncolytic Reovirus Distribution and Replication In-Human Tumors.

View publication online

Conferences: 2023

21st November 2023

LSPN Europe 2023

Attended

Event details

Related News

Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

LSPN Europe 2023

HGF are gold sponsors of LSPN Europe which is due to go ahead at BMA House, Tavistock Square in London on 21st November. This event will explore some of the …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us